Susquehanna International Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $280K | Sell |
9,800
-22,700
| -70% | -$775K | ﹤0.01% | 11032 |
|
|
2025
Q4 | $1.29M | Buy |
32,500
+12,800
| +65% | +$469K | ﹤0.01% | 6603 |
|
|
2025
Q3 | $694K | Sell |
19,700
-3,500
| -15% | -$121K | ﹤0.01% | 8213 |
|
|
2025
Q2 | $760K | Sell |
23,200
-2,500
| -10% | -$81.2K | ﹤0.01% | 8148 |
|
|
2025
Q1 | $829K | Buy |
25,700
+12,200
| +90% | +$453K | ﹤0.01% | 7726 |
|
|
2024
Q4 | $413K | Buy |
+13,500
| New | +$434K | ﹤0.01% | 9137 |
|
|
2024
Q3 | – | Sell |
-88,200
| Closed | -$2.01M | – | 11927 |
|
|
2024
Q2 | $2.01M | Buy |
88,200
+62,300
| +241% | +$1.44M | ﹤0.01% | 5097 |
|
|
2024
Q1 | $788K | Buy |
25,900
+20,000
| +339% | +$670K | ﹤0.01% | 7444 |
|
|
2023
Q4 | $211K | Buy |
+5,900
| New | +$219K | ﹤0.01% | 10576 |
|
|
2023
Q3 | – | Sell |
-6,900
| Closed | -$341K | – | 11982 |
|
|
2023
Q2 | $341K | Buy |
6,900
+1,600
| +30% | +$73.7K | ﹤0.01% | 9181 |
|
|
2023
Q1 | $220K | Sell |
5,300
-900
| -15% | -$37.3K | ﹤0.01% | 10395 |
|
|
2022
Q4 | $275K | Buy |
+6,200
| New | +$259K | ﹤0.01% | 9298 |
|
|
2022
Q1 | – | Sell |
-4,200
| Closed | -$292K | – | 12941 |
|
|
2021
Q4 | $292K | Sell |
4,200
-1,000
| -19% | -$72.7K | ﹤0.01% | 10558 |
|
|
2021
Q3 | $362K | Sell |
5,200
-2,100
| -29% | -$162K | ﹤0.01% | 10156 |
|
|
2021
Q2 | $579K | Buy |
7,300
+3,300
| +83% | +$240K | ﹤0.01% | 9243 |
|
|
2021
Q1 | $262K | Buy |
4,000
+200
| +5% | +$12.3K | ﹤0.01% | 10886 |
|
|
2020
Q4 | $212K | Sell |
3,800
-4,700
| -55% | -$203K | ﹤0.01% | 9940 |
|
|
2020
Q3 | $339K | Sell |
8,500
-7,800
| -48% | -$331K | ﹤0.01% | 8461 |
|
|
2020
Q2 | $733K | Buy |
16,300
+1,300
| +9% | +$56.6K | ﹤0.01% | 6570 |
|
|
2020
Q1 | $504K | Buy |
15,000
+5,300
| +55% | +$191K | ﹤0.01% | 6918 |
|
|
2019
Q4 | $315K | Sell |
9,700
-19,700
| -67% | -$561K | ﹤0.01% | 7916 |
|
|
2019
Q3 | $733K | Buy |
29,400
+18,000
| +158% | +$514K | ﹤0.01% | 6400 |
|
|
2019
Q2 | $340K | Buy |
+11,400
| New | +$333K | ﹤0.01% | 8074 |
|
|
2019
Q1 | – | Sell |
-9,800
| Closed | -$300K | – | 8787 |
|
|
2018
Q4 | $300K | Buy |
9,800
+800
| +9% | +$24.9K | ﹤0.01% | 6996 |
|
|
2018
Q3 | $315K | Buy |
+9,000
| New | +$285K | ﹤0.01% | 7394 |
|
|
2017
Q3 | – | Sell |
-12,700
| Closed | -$308K | – | 8780 |
|
|
2017
Q2 | $308K | Buy |
+12,700
| New | +$270K | ﹤0.01% | 7545 |
|
|
2016
Q4 | – | Sell |
-15,300
| Closed | -$242K | – | 9543 |
|
|
2016
Q3 | $242K | Sell |
15,300
-700
| -4% | -$10.8K | ﹤0.01% | 7276 |
|
|
2016
Q2 | $226K | Buy |
+16,000
| New | +$244K | ﹤0.01% | 7401 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Susquehanna International Group's ATRC Position: Q1 2026 in Review
Susquehanna International Group opened a new position in AtriCure (ATRC) in Q1 2026: 38,777 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #7613 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ATRC as recently as Q2 2025.
Susquehanna International Group first reported a position in ATRC in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.51M in Q1 2020. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Susquehanna International Group held 38,777 shares of AtriCure worth $1.11M as of Q1 2026.
- AtriCure was a new Susquehanna International Group position in Q1 2026.
- AtriCure made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7613 holding.
- Susquehanna International Group first reported a position in AtriCure in Q4 2016 and has held it in 22 quarters since.
- Susquehanna International Group's AtriCure position peaked at $2.51M in Q1 2020.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.